Levdobutamine

A synthetic catecholamine used in cardiac care

Levdobutamine is a synthetic catecholamine and a beta-adrenergic agonist primarily used in the management of heart failure and cardiogenic shock. It is the levorotatory isomer of dobutamine, which is a well-known inotrope used to increase cardiac output in patients with acute heart conditions.

Pharmacology

Levdobutamine acts on the beta-1 adrenergic receptors in the heart, leading to increased myocardial contractility and heart rate. This results in enhanced cardiac output, which is beneficial in conditions where the heart's pumping ability is compromised. Unlike some other catecholamines, levdobutamine has a relatively selective action on beta-1 receptors, which minimizes peripheral vasoconstriction and reduces the risk of increased afterload.

Mechanism of Action

Levdobutamine works by stimulating the beta-1 adrenergic receptors, which are coupled to G-proteins. This stimulation activates adenylate cyclase, increasing the levels of cyclic adenosine monophosphate (cAMP) in cardiac cells. Elevated cAMP levels enhance the influx of calcium ions during the cardiac action potential, thereby increasing the force of contraction of the heart muscle.

Clinical Use

Levdobutamine is used in the treatment of acute heart failure and cardiogenic shock, particularly in settings where rapid improvement in cardiac output is desired. It is administered intravenously, allowing for quick titration and adjustment of dosage based on the patient's hemodynamic response.

Side Effects

Common side effects of levdobutamine include tachycardia, arrhythmias, and hypertension. Due to its positive inotropic effects, it can also increase myocardial oxygen demand, which may exacerbate ischemia in patients with coronary artery disease.

Comparison with Dobutamine

While both levdobutamine and dobutamine are used to increase cardiac output, levdobutamine is the levorotatory isomer and may have different pharmacokinetic properties. The clinical significance of these differences is still a subject of research, but levdobutamine's more selective action on beta-1 receptors may offer advantages in certain clinical scenarios.

Chemical Structure

Chemical structure of Levdobutamine

Levdobutamine is a chiral compound with a specific three-dimensional arrangement that allows it to interact selectively with beta-1 adrenergic receptors. Its chemical structure is similar to that of other catecholamines, featuring a catechol moiety and an amine group.

Related pages

• Dobutamine
• Catecholamine
• Beta-adrenergic agonist
• Heart failure
• Cardiogenic shock